US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

iShares Biotechnology ETF

205.29

-0.6700-0.33%

Post-market: 204.90-0.3900-0.19%19:54 EDT

Volume:2.09M

Turnover:428.42M

Market Cap:10.42B

PE:32.52

High:206.99

Open:206.85

Low:204.14

Close:205.96

52wk High:217.12

52wk Low:147.95

Shares:50.75M

Float Shares:50.75M

Volume Ratio:1.45

T/O Rate:4.12%

Dividend:0.34

Dividend Rate:0.16%

EPS(TTM):6.31

EPS(LYR):35.34

ROE:24.54%

ROA:0.10%

PB:1.28

PE(LYR):5.81

Loading ...

Overview Company News Filings

Vertex Says Phase 2b Amplified Study Shows Inaxaplin Cuts Proteinuria in APOL1-Mediated Kidney Disease Patients with Modest Proteinuria

Vertex Pharmaceuticals Incorporated - Inaxaplin Reduces Uacr by -42.7% at Week 13 in Amkd with Modest Proteinuria

THOMSON REUTERS

Vertex Pharmaceuticals Incorporated - Inaxaplin Generally Safe and Well Tolerated in Both Amkd Cohorts

THOMSON REUTERS

Vertex Announces Positive Results from Phase 2B Amplified Study of Inaxaplin in Additional Populations of People with Apol1-Mediated Kidney Disease (Amkd) and Completion of Enrollment in the Phase 2/3 Amplitude Trial

THOMSON REUTERS

Analysts Offer Insights on Healthcare Companies: Amgen (AMGN), Invivyd (IVVD) and Humacyte (HUMA)

Sino Biopharmaceutical Stock Slips 1.4% in Hong Kong, Underperforms Competitors

Kolmar Biotech Finalizes Low-Risk Merger of Wholly Owned Unit MOD Materials

Nexsen Seeks ASX Trading Halt Ahead of RAPID-GBS Trial Update

iShares Biotechnology ETF Announces Dividend of R$ 0.002579964 Per Unit

Moderna Inc. Stock Climbs 12.3%, Outperforms Peers

Sector Update: Healthcare

MT Newswires Live

Exchange-Traded Funds Rise as US Equities Advance After Midday

MT Newswires Live

Sector Update: Healthcare

MT Newswires Live

InspireMD Announces Amendments to Certain Series J and Series K Warrants, Providing Potential Gross Proceeds of Up to $11 Million

Tiziana Life Sciences Completes Last Patient Visit in Phase 2a INFORM-MS Trial

Immunome initiated with a Buy at Alliance Global

Vertex Pharmaceuticals Incorporated : Leerink Partners Resumes Coverage with Outperform Rating; Target Price $594

THOMSON REUTERS

Ultragenyx price target raised to $35 from $32 at Barclays

Sino Biopharmaceutical Stock Rises 8.2% in Hong Kong, Outperforms Competitors

Innovative Drug Sector Heats Up: Spotlight on Pure-Play R&D Developers

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://hk.tigeractivity.com/stock/IBB/news?page=10"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"IBB","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"IBB\",,,,,undefined,":{"symbol":"IBB","market":"US","secType":"STK","nameCN":"iShares Biotechnology ETF","latestPrice":205.29,"timestamp":1790971200000,"preClose":205.96,"halted":0,"volume":2090367,"hourTrading":{"tag":"盘后","latestPrice":204.9,"preClose":205.29,"latestTime":"19:54 EDT","volume":4650,"amount":954020.013,"timestamp":1790985282565,"change":-0.39,"changeRate":-0.0019,"amplitude":0.0019},"delay":0,"changeRate":-0.0032530588463780146,"floatShares":50750000,"shares":50750000,"eps":6.311863,"marketStatus":"Market Closed","change":-0.67,"latestTime":"10-02 16:00:00 EDT","open":206.85,"high":206.99,"low":204.14,"amount":428424270.2739,"amplitude":0.013838,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":1,"ttmEps":6.311863,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1791187200000},"marketStatusCode":7,"adr":0,"adrRate":0,"exchange":"NASDAQ","adjPreClose":205.96,"sharesOutstanding":49450000,"nav":205.906616,"aum":10583600062.4,"dividendRate":0.001642,"bidAskSpread":0.000461,"preHourTrading":{"tag":"盘前","latestPrice":208.1204,"preClose":205.96,"latestTime":"09:25 EDT","volume":1539,"amount":319122.80775,"timestamp":1790947530966,"change":2.1604,"changeRate":0.010489,"amplitude":0.02282},"postHourTrading":{"tag":"盘后","latestPrice":204.9,"preClose":205.29,"latestTime":"19:54 EDT","volume":4650,"amount":954020.013,"timestamp":1790985282565,"change":-0.39,"changeRate":-0.0019,"amplitude":0.0019},"volumeRatio":1.45129,"impliedVol":0.2363,"impliedVolPercentile":0.498},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"IBB\",,,,,undefined,":{"symbol":"IBB","floatShares":50750000,"roa":"0.10%","roe":"24.54%","lyrEps":35.344796,"volumeRatio":1.45129,"shares":50750000,"dividePrice":0.3371,"high":206.99,"amplitude":0.013838,"preClose":205.96,"low":204.14,"week52Low":147.95,"pbRate":"1.28","psRate":"250.66","week52High":217.12,"institutionHeld":0,"latestPrice":205.29,"eps":6.311863,"divideRate":0.001642,"volume":2090367,"delay":0,"ttmEps":6.311863,"open":206.85,"prevYearClose":168.77,"prevWeekClose":209.77,"prevMonthClose":210.53,"prevQuarterClose":210.53,"fiveDayClose":209.77,"twentyDayClose":213.81,"sixtyDayClose":197.34},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/IBB\",params:#limit:5,,,undefined,":[{"date":"2026-09-15","symbol":"IBB","amount":0.011194,"announcedDate":"2026-09-14","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-09-15","defaultRemindTime":1789479000000,"name":"生物科技指数ETF-iShares Nasdaq","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-09-18","payableDate":"2026-09-15","currency":"USD","dateTimestamp":1789444800000,"payDate":"2026-09-18"},{"date":"2026-06-15","symbol":"IBB","amount":0.023774,"announcedDate":"2026-06-12","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-06-15","defaultRemindTime":1781530200000,"name":"生物科技指数ETF-iShares Nasdaq","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-06-18","payableDate":"2026-06-15","currency":"USD","dateTimestamp":1781496000000,"payDate":"2026-06-18"},{"date":"2026-03-17","symbol":"IBB","amount":0.121818,"announcedDate":"2026-03-16","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-03-17","defaultRemindTime":1773754200000,"name":"生物科技指数ETF-iShares Nasdaq","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-03-20","payableDate":"2026-03-17","currency":"USD","dateTimestamp":1773720000000,"payDate":"2026-03-20"},{"date":"2025-12-16","symbol":"IBB","amount":0.183099,"announcedDate":"2025-12-15","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-12-16","defaultRemindTime":1765895400000,"name":"生物科技指数ETF-iShares Nasdaq","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-12-19","payableDate":"2025-12-16","currency":"USD","dateTimestamp":1765861200000,"payDate":"2025-12-19"},{"date":"2025-09-16","symbol":"IBB","amount":0.082843,"announcedDate":"2025-09-15","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-09-16","defaultRemindTime":1758029400000,"name":"生物科技指数ETF-iShares Nasdaq","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-09-19","payableDate":"2025-09-16","currency":"USD","dateTimestamp":1757995200000,"payDate":"2025-09-19"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"IBB\",market:\"US\",,,undefined,":[{"executeDate":"2016-12-22","recordDate":"2016-12-27","paymentDate":"2016-12-29","value":0.091903,"currency":"USD"},{"executeDate":"2017-03-24","recordDate":"2017-03-28","paymentDate":"2017-03-30","value":0.29898,"currency":"USD"},{"executeDate":"2017-06-27","recordDate":"2017-06-29","paymentDate":"2017-06-30","value":0.176803,"currency":"USD"},{"executeDate":"2017-09-26","recordDate":"2017-09-27","paymentDate":"2017-09-29","value":0.118654,"currency":"USD"},{"executeDate":"2018-06-26","recordDate":"2018-06-27","paymentDate":"2018-07-02","value":0.15606,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"IBB\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"IBB\",pageSize:20,pageCount:10,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2669177141","title":"Vertex Says Phase 2b Amplified Study Shows Inaxaplin Cuts Proteinuria in APOL1-Mediated Kidney Disease Patients with Modest Proteinuria","url":"https://stock-news.laohu8.com/highlight/detail?id=2669177141","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669177141?lang=en_us&edition=fundamental","pubTime":"2026-09-22 20:02","pubTimestamp":1790078577,"startTime":"0","endTime":"0","summary":"Vertex says Phase 2b AMPLIFIED study shows inaxaplin cuts proteinuria in APOL1-mediated kidney disease patients with modest proteinuriaVertex reported positive Phase 2b AMPLIFIED results for inaxaplin","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260922:nNDL8CHhBr:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BBH","IE0002141913.USD","LU0823416689.USD","IE00B19Z9Z06.USD","SGXZ57979304.SGD","IDNA","LU0889565916.HKD","TBXU","LU0061475181.USD","LU1674673691.USD","BK4588","LU2362541513.USD","LU1035775433.USD","LU2462157665.USD","LU0079474960.USD","LU0256863811.USD","VRTX","LU1093756168.USD","LU1674673428.USD","BK4532","PBE","IE00B19Z3B42.SGD","BK4567","LU2324357040.USD","SG9999013999.USD","IE00B19Z9P08.USD","BK4139","IE00B19Z3581.USD","IE00BFTCPJ56.SGD","IE00BJT1NW94.SGD","SG9999001176.SGD","IE00BZ9MQY76.HKD","IE0002270589.USD","IBB","LU2089984988.USD","BIB","LU0058720904.USD","LU1069344957.HKD","GNMX","LU0320765992.SGD","IBBQ","LU2468319806.SGD","LU2362541273.HKD","LU2237438978.USD","IE0009355771.USD","BK4585","LU0109394709.USD","IE00B2B36J28.USD","LU1093756325.SGD","LU0432979614.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669419861","title":"Vertex Pharmaceuticals Incorporated - Inaxaplin Reduces Uacr by -42.7% at Week 13 in Amkd with Modest Proteinuria","url":"https://stock-news.laohu8.com/highlight/detail?id=2669419861","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669419861?lang=en_us&edition=fundamental","pubTime":"2026-09-22 20:00","pubTimestamp":1790078403,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260922:nTUA6RPXRQ:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU2468319806.SGD","LU1778281490.HKD","SG9999001176.SGD","BK4585","LU0234570918.USD","LU1585245621.USD","IDNA","LU2237438978.USD","IBB","LU2462157665.USD","IE00B19Z3581.USD","BIB","IBBQ","IE00B19Z9Z06.USD","LU0256863811.USD","BBH","IE00B4R5TH58.HKD","LU0889565916.HKD","LU0417517546.SGD","IE0002141913.USD","LU1069344957.HKD","LU2236285917.USD","LU1674673691.USD","LU1093756168.USD","IE00B2B36J28.USD","LU2324357040.USD","TBXU","LU1093756325.SGD","LU1674673428.USD","IE00BJJMRZ35.SGD","LU0079474960.USD","IE00B894F039.SGD","LU2362541513.USD","LU0109394709.USD","IE0002270589.USD","IE0009355771.USD","BK4139","IE00BJT1NW94.SGD","LU2362540622.SGD","LU2362541273.HKD","SGXZ57979304.SGD","LU2417539215.USD","GNMX","IE00B19Z9P08.USD","VRTX","LU1430594728.SGD","PBE","LU0823416689.USD","LU2456880835.USD","LU0289739699.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669419041","title":"Vertex Pharmaceuticals Incorporated - Inaxaplin Generally Safe and Well Tolerated in Both Amkd Cohorts","url":"https://stock-news.laohu8.com/highlight/detail?id=2669419041","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669419041?lang=en_us&edition=fundamental","pubTime":"2026-09-22 20:00","pubTimestamp":1790078403,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260922:nTUA6RPXRQ:4","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU0058720904.USD","LU1069344957.HKD","BBH","LU0109394709.USD","LU0234570918.USD","SG9999001176.USD","IE0002270589.USD","LU0061475181.USD","LU0889565916.HKD","LU2237438978.USD","IE00BZ9MQY76.HKD","LU2324357040.USD","LU2362541513.USD","SG9999013999.USD","LU2362541273.HKD","BK4588","IE0002141913.USD","LU2456880835.USD","IE00BJJMRZ35.SGD","LU0079474960.USD","LU2417539215.USD","PBE","IBB","BK4585","VRTX","BK4139","BK4533","IE00B19Z9Z06.USD","IBBQ","LU1093756325.SGD","LU2462157665.USD","SGXZ57979304.SGD","TBXU","LU1035775433.USD","IDNA","BK4532","IE00BJT1NW94.SGD","IE00B4R5TH58.HKD","LU1585245621.USD","LU0256863811.USD","IE00B19Z9P08.USD","LU0432979614.USD","LU1778281490.HKD","BK4567","GNMX","LU0320765992.SGD","BIB","LU2089984988.USD","SG9999001176.SGD","LU1674673428.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669141954","title":"Vertex Announces Positive Results from Phase 2B Amplified Study of Inaxaplin in Additional Populations of People with Apol1-Mediated Kidney Disease (Amkd) and Completion of Enrollment in the Phase 2/3 Amplitude Trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2669141954","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669141954?lang=en_us&edition=fundamental","pubTime":"2026-09-22 20:00","pubTimestamp":1790078403,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260922:nTUA6RPXRQ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["IBB","IE00BZ9MQY76.HKD","SG9999001176.USD","LU0889565916.HKD","LU1674673428.USD","IE00B19Z9P08.USD","IE00B19Z3581.USD","LU2236285917.USD","IE00B2B36J28.USD","LU0109394709.USD","BK4532","LU2089984988.USD","BBH","BK4139","BK4567","LU0417517546.SGD","LU0256863811.USD","LU1778281490.HKD","TBXU","LU0061475181.USD","IE0002141913.USD","LU0823416689.USD","SGXZ57979304.SGD","SG9999013999.USD","LU1585245621.USD","LU2237438978.USD","IDNA","LU0234570918.USD","GNMX","IE00B19Z3B42.SGD","PBE","IE0002270589.USD","LU1069344957.HKD","IE00BJT1NW94.SGD","LU0432979614.USD","BK4533","LU1093756325.SGD","LU1035775433.USD","LU0058720904.USD","IBBQ","SG9999001176.SGD","VRTX","LU1674673691.USD","BIB","LU0079474960.USD","IE00B4R5TH58.HKD","LU0320765992.SGD","LU0289739699.SGD","LU2456880835.USD","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669143096","title":"Analysts Offer Insights on Healthcare Companies: Amgen (AMGN), Invivyd (IVVD) and Humacyte (HUMA)","url":"https://stock-news.laohu8.com/highlight/detail?id=2669143096","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669143096?lang=en_us&edition=fundamental","pubTime":"2026-09-22 18:10","pubTimestamp":1790071809,"startTime":"0","endTime":"0","summary":"Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Amgen (AMGN), Invivyd (IVVD) and Humacyte (HUMA). ...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-amgen-amgn-invivyd-ivvd-and-humacyte-huma-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-amgen-amgn-invivyd-ivvd-and-humacyte-huma-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU0889565916.HKD","PJP","BBH","XBI","BIB","BK4534","LU2468319806.SGD","XLV","LU1571399168.USD","LU0029874061.USD","LU2089984988.USD","IE00BJJMRZ35.SGD","BK4599","HCSG","BK4588","LU0320765992.SGD","BK4585","IE0002141913.USD","LU0109394709.USD","LU2242646821.SGD","LU0868494617.USD","IE0009355771.USD","BK4137","LU1023059063.AUD","AMGN","IE00B4R5TH58.HKD","IE00B2B36J28.USD","LU1057294990.SGD","BK4539","LU0058720904.USD","LU0122379950.USD","LU1061106388.HKD","LU1983299246.USD","LABU","BK4533","LU0289739699.SGD","IBBQ","IVVD","PBE","LU0128526141.USD","BK4139","BK4566","LU2242652126.USD","HUMA","BK4563","SG9999001440.SGD","TBXU","IE00BJT1NW94.SGD","IE00BFTCPJ56.SGD","IBB"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669511784","title":"Sino Biopharmaceutical Stock Slips 1.4% in Hong Kong, Underperforms Competitors","url":"https://stock-news.laohu8.com/highlight/detail?id=2669511784","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669511784?lang=en_us&edition=fundamental","pubTime":"2026-09-22 16:32","pubTimestamp":1790065920,"startTime":"0","endTime":"0","summary":"This article was automatically generated by Dow Jones using technology from Automated Insights.Shares of Sino Biopharmaceutical Ltd. slipped 1.4% to 5.84 Hong Kong dollars on what proved to be an all-around positive trading session for the Hong Kong stock market, with the Hang Seng Index rising 0.2% to 25087.75.Sino Biopharmaceutical Ltd. closed 32% short of its 52-week high of HK$8.56, which the company reached Sept. 23.The stock underperformed when compared to some of its competitors, as CSPC Pharmaceutical Group Ltd. rose 1.1% and Amgen Inc. remained unchanged.Trading volume totaled 87.2 million shares, compared to the 50-day average of 88.8 million shares.Data source: Dow Jones Market Data, FactSet","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","LU1571399168.USD","LU2242652126.USD","SG9999001440.SGD","IE00BFTCPJ56.SGD","LU2468319806.SGD","LU2089984988.USD","BK1521","BK4585","IE00BJJMRZ35.SGD","LU2242646821.SGD","IBBQ","BK1515","BK4581","AMGN","HK0000165453.HKD","IE00BZ08YS42.EUR","IE00B4R5TH58.HKD","LU0289739699.SGD","BK1589","IE00BZ08YR35.GBP","LU0058720904.USD","PBE","LU0122379950.USD","BK4566","LU0889565916.HKD","LU2112291526.USD","BK4588","BK4599","BK4534","IE0002141913.USD","LU0868494617.USD","LU1057294990.SGD","LU0320765992.SGD","IBB","01177","PJP","IE00BZ08YT58.USD","LU0109394709.USD","IE00B2B36J28.USD","LU1061106388.HKD","BK1191","TBXU","LU1023059063.AUD","IE00BJT1NW94.SGD","BBH","LU1983299246.USD","BIB","IE0009355771.USD","BK4533"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669192951","title":"Kolmar Biotech Finalizes Low-Risk Merger of Wholly Owned Unit MOD Materials","url":"https://stock-news.laohu8.com/highlight/detail?id=2669192951","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669192951?lang=en_us&edition=fundamental","pubTime":"2026-09-22 09:14","pubTimestamp":1790039644,"startTime":"0","endTime":"0","summary":"WOOJUNG BIO, Inc. ( ($KR:215380) ) has issued an update. Kolmar Biotech Co., Ltd., a biotechnology and advanced materials company based in Hwaseong...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/kolmar-biotech-finalizes-low-risk-merger-of-wholly-owned-unit-mod-materials?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/kolmar-biotech-finalizes-low-risk-merger-of-wholly-owned-unit-mod-materials?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4544","BBP","SYNB","IBB","BK4588","FWD","BK4585","UYM","LNGR","BK4581","ARKG","XBI","TYNE","AGNG","RSPH","IEIH","JDOC","DARP","TINT","FHLC","XT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669199837","title":"Nexsen Seeks ASX Trading Halt Ahead of RAPID-GBS Trial Update","url":"https://stock-news.laohu8.com/highlight/detail?id=2669199837","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669199837?lang=en_us&edition=fundamental","pubTime":"2026-09-22 07:34","pubTimestamp":1790033657,"startTime":"0","endTime":"0","summary":"Nexsen Limited ( ($AU:NXN) ) just unveiled an announcement. Nexsen Limited, trading on the ASX as NXN, operates in the healthcare and biotechnology...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/nexsen-seeks-asx-trading-halt-ahead-of-rapid-gbs-trial-update?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/nexsen-seeks-asx-trading-halt-ahead-of-rapid-gbs-trial-update?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["FWD","VHT","JDOC","XT","AGNG","IBB","FHLC","DARP","BK4585","RSPH","LNGR","BBP","CGCV","SYNB","BK4550","IXJ","NOBL","IEIH","BK4588","TCAF"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669819362","title":"iShares Biotechnology ETF Announces Dividend of R$ 0.002579964 Per Unit","url":"https://stock-news.laohu8.com/highlight/detail?id=2669819362","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669819362?lang=en_us&edition=fundamental","pubTime":"2026-09-22 04:51","pubTimestamp":1790023874,"startTime":"0","endTime":"0","summary":"iShares Biotechnology ETF announces dividend of R$ 0.002579964 per unitiShares Biotechnology ETF announced a 3Q 2026 dividend of R$ 0.002579964 per unit.Units trade ex-dividend on Sept. 15, 2026.Payme","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260921:nNDL718W0J:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4588","BK4585","IBB"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669619383","title":"Moderna Inc. Stock Climbs 12.3%, Outperforms Peers","url":"https://stock-news.laohu8.com/highlight/detail?id=2669619383","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669619383?lang=en_us&edition=fundamental","pubTime":"2026-09-22 04:33","pubTimestamp":1790022780,"startTime":"0","endTime":"0","summary":"This article was automatically generated by Dow Jones using technology from Automated Insights.Shares of Moderna Inc. jumped 12.3% to $172.94 on what proved to be an all-around favorable trading session for the stock market, with the NASDAQ Composite Index rising 2.3% to 27,122.09 and the Dow Jones Industrial Average rising 0.7% to 52,048.83.Moderna Inc. closed 2.1% short of its 52-week high of $176.66, which the company reached on August 19th.The stock outperformed some of its peers, as Johnson & Johnson fell 0.2% to $269.47, Pfizer Inc. rose 0.3% to $27.74, and Gilead Sciences Inc. rose 0.30% to $150.56.Trading volume totaled 20.9 million, compared to the 50-day average of 17.9 million.Data source: Dow Jones Market Data, FactSet","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0058720904.USD","LU1066051498.USD","BBH","LU0109394709.USD","LU0234570918.USD","SG9999015986.USD","TMED","IE0002270589.USD","LGHT","LU1839511570.USD","LU0122379950.USD","LU0889565916.HKD","LU1934455194.USD","BK4534","GNOM","IE00BSNM7G36.USD","LU2089984988.USD","LU1066053197.SGD","MRNX","IBB","IE00B7SZLL34.SGD","BK4501","BK4139","BK4533","TBXU","IBBQ","LU0289739699.SGD","IDNA","BK4532","LU0859254822.USD","MEDI","MRNY","BK4548","MRNA","BMED","LU1778281490.HKD","LU1430594728.SGD","LU0861579265.USD","LU2468319806.SGD","SG9999015952.SGD","LU0882574055.USD","LU0320765992.SGD","BK4578","LU0965509101.SGD","BIB","LU1023059063.AUD","WDNA","GILD","LU1674673428.USD","LU1061106388.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669081160","title":"Sector Update: Healthcare","url":"https://stock-news.laohu8.com/highlight/detail?id=2669081160","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669081160?lang=en_us&edition=fundamental","pubTime":"2026-09-22 03:21","pubTimestamp":1790018463,"startTime":"0","endTime":"0","summary":"Healthcare stocks rose late Monday afternoon with the NYSE Healthcare Index increasing 0.6% and the State Street Health Care Select Sector SPDR ETF  adding 0.8%.The iShares Biotechnology ETF  climbed 1.4%.In corporate news, Eli Lilly's  oral drug Foundayo now makes up one-third of new GLP-1 pill patients, CNBC reported, citing CEO Dave Ricks. Lilly broke ground on a $6.5 billion Houston manufacturing plant expected to be operational by 2030, the report also said. Lilly shares rose 0.9%.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LU0006306889.USD","ELIS","GB00BDT5M118.USD","LU0203202063.USD","LU2552382215.SGD","LU2089283258.USD","LU0094547139.USD","LU0672654240.SGD","LU1720051108.HKD","LLY","LU2361044865.SGD","LU0466842654.USD","LU0683600562.USD","IXJ","XLV","LU0106261372.USD","LU1064131342.USD","SG9999015986.USD","LU0122379950.USD","LU2491049909.HKD","LU2211815571.USD","LU2461242641.AUD","BK4599","IE00B1BXHZ80.USD","IE00BWXC8680.SGD","LU2106854487.HKD","LU1093756168.USD","IE00B4JS1V06.HKD","LU0354030438.USD","SG9999018857.SGD","LU2237443895.HKD","LU1979441026.SGD","RXL","LU0234572021.USD","LU0820561909.HKD","LU1814569148.SGD","ELIL","LU0210536198.USD","LU0417517546.SGD","LU2237443622.USD","LU2417539215.USD","LU2750360997.AUD","SG9999001176.SGD","LU0964807845.USD","LU2468319806.SGD","SGXZ51526630.SGD","LU0198837287.USD","LU1366192091.USD","LU2237443465.HKD","LU2471134796.USD","LU1127390331.HKD","LU2456880835.USD","LU0823416689.USD","IE00B4R5TH58.HKD","LU2462591350.SGD","LU0882574055.USD","LU0689472784.USD","SG9999001176.USD","LU1804176565.USD","IE00B2B36J28.USD","CURE","IE00BFSS8Q28.SGD","LU2168563687.JPY","LU2746668461.USD","LU2111349929.HKD","LU2357305700.SGD","LU0786609619.USD","LU0787776722.HKD","LU2168564149.EUR","LU2756315318.SGD","SG9999015952.SGD","FHLC","IE00BKPKM429.USD","IE00BJT1NW94.SGD","LU0097036916.USD","LU2023250330.USD","LU2237438978.USD","IE0004445015.USD","LU0133085943.USD","LU0203201768.USD","LU2237443549.SGD","LU2491050154.USD","LU0061475181.USD","BK4585","BK4588","LU0316494557.USD","SGXZ31699556.SGD","IE00BK4W5M84.HKD","IE0004445239.USD","LU1691799644.USD","LU1712237335.SGD","SGXZ57979304.SGD","LU2028103732.USD","IE0001KFT4U8.USD","LU2471134879.HKD","WDNA","LU0114720955.EUR","LU0158827781.USD","IE00BK4W5L77.USD","LU2063271972.USD","LU1629891620.HKD","LU1983299246.USD","GDOC","OZEM","IE0005OL40V9.USD","LU2602419157.SGD","IHE","LU2552382132.HKD","LU2360106947.USD","IE0009355771.USD","LU0820562030.AUD","LU2462157665.USD","LU1548497426.USD","LU1551013425.SGD","IE00BJJMRZ35.SGD","LU2213496289.HKD","LU1868837136.USD","LU1232071149.USD","LU2746668974.SGD","LU1868836757.USD","MEDX","LU0256863902.USD","LU0432979614.USD","LU1093756325.SGD","LU1323610961.USD","LU1868836914.USD","LU2168564222.USD","IE00BN29S564.USD","LU1057294990.SGD","FTXH","IE00BJJMRX11.SGD","IE00BJJMRY28.SGD","LU2168564495.EUR","LU0882574139.USD","LU1917777945.USD","LU0820561818.USD","SGXZ81514606.USD","LU0456855351.SGD","TMED","LABU","LU0345770993.USD","LU1061106388.HKD","LU1720051017.SGD","LU2089984988.USD","LU2265009873.SGD","LU2089284900.SGD","LU2237443382.USD","MEDI","IE00BFSS7M15.SGD","SG9999018865.SGD","THNR","LU0943347566.SGD","LU2168564065.EUR","LU1974910355.USD","HRTS","LU0096364046.USD","LU0385154629.USD","LU1623119135.USD","LU2237443978.SGD","LU0238689110.USD","LU1145028129.USD","LU2471134523.USD","PJP","LU0823434583.USD","BK4534","IE0002141913.USD","SGXZ99366536.SGD","IBB","LU2271345857.HKD","LU2023250504.SGD","AGNG","MHIP","SG9999014898.SGD","XBI","LU2756315664.SGD","SG9999015978.USD","ILDR","JDOC","LU0320765992.SGD","LU2491050071.SGD","LU1035775433.USD","LU1023059063.AUD","TRUH","LU1868836591.USD","LU0058720904.USD","IE00B1XK9C88.USD","LU2236285917.USD","LU2896262040.SGD","LU1551013342.USD","LU2324357040.USD","IE00B7KXQ091.USD","LU0823434740.USD","LU1989771016.USD","LU1988902786.USD","SG9999014914.USD","LLII","LU2552382058.USD","LU1069344957.HKD","LU1267930730.SGD","LU0353189680.USD","SG9999013999.USD","IYH","LU0471298694.HKD","LU0174119429.USD","LU1291159041.SGD","IE00BJLML261.HKD","IE00BKDWB100.SGD","LU0079474960.USD","LU2023251221.USD","LU2750360641.GBP","LU0320765059.SGD","BK4007","LU0471298777.SGD","LU2087625088.SGD","LLYX","LU0889565916.HKD","BK4533","LU2112291526.USD","BK4581","LU2361045086.USD","LU0708995401.HKD","LU2361044949.HKD","VHT","LU0640476718.USD","LU0323591593.USD","LU0109394709.USD","LU0345770308.USD","SG9999014906.USD","LU1280957306.USD","SG9999014880.SGD","LU0354030511.USD","IE00B775H168.HKD","LU0158827948.USD","LU0225283273.USD","CANC","LU0353189763.USD","BK4516","SG9999015945.SGD","LU0109391861.USD","LLYZ","LU0289739699.SGD","IE00BFTCPJ56.SGD","LU1868837300.USD","LU2108987350.USD","LU0266013472.USD","LU2264538146.SGD","LU2471134952.CNY","SG9999017495.SGD","LU0256863811.USD","PPH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669538167","title":"Exchange-Traded Funds Rise as US Equities Advance After Midday","url":"https://stock-news.laohu8.com/highlight/detail?id=2669538167","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669538167?lang=en_us&edition=fundamental","pubTime":"2026-09-22 01:07","pubTimestamp":1790010473,"startTime":"0","endTime":"0","summary":"Broad Market IndicatorsBroad-market exchange-traded funds IWM and IVV were higher. Actively traded Invesco QQQ Trust (QQQ) added 2.5%.US equity indexes rose as mega-cap technology names perked up amid","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["RTH","BITI","BFAP","XAGUSD.FOREX","BK4585","BITU","IYJ","QBF","XBI","PSQ","BK4588","TQQQ","BTF","AGQ","BCCC","IAU","BTCO","XLE","ETCO","FAZ","VIS","IBIT","ETHD","IYH","LABU","BTCI","BTC","CBOA","BITB","SLV","BTCC","CBTY","QMAR","TETH","TQQY","CBXJ","BITX","QQQX","BGLD","EZBC","UNG","MAXI","BRRR","DULL","XLPU","SOXS","SHNY","SBIT","DGP","BTC.USD.CC","IBB","XAUUSD.FOREX","ETQ","GCPU","BK4593","DEFI","NOCT","BETH","IYE","BAGY","QLD","IGM","GLDY","BK4504","BK4550","XLPD","NJAN","HODL","CBTO","RETL","XRT","SETH","SOXX","NJUL","XLF","BTCW","ESK","BFJL","NAPR","XBTY","BK4561","BK4534","XLV","MNRS","BK4547","CBXY","XSD","BETE","QID","CBOJ","BTRN","BTCZ","VDC","XLI","GPIQ","GLD","BITY","DZZ","IAUM","YBTC","QQQM","BPI","DGZ","BTCL","FBTC","USG","ETH.USD.CC","OUNZ","BK4581","BAR","SOXL","YGLD","QQQ","VHT","GLDM","CBTJ","SGOL","UGL","BITO","ZSL","TECL","EETH","AAAU","CBTA","GBTC","ETHT","IYW","XLK","USO","SIVR","IGLD","CBXO","CBOY","FGDL","UCO","ETH","GLL","ARKB","SQQQ","DFII","CBOO","KGLD","XLY","NDX","BK4570","QDEC","XLP","CBXA","FAS","IAUI","SCO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669668841","title":"Sector Update: Healthcare","url":"https://stock-news.laohu8.com/highlight/detail?id=2669668841","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669668841?lang=en_us&edition=fundamental","pubTime":"2026-09-21 21:01","pubTimestamp":1789995684,"startTime":"0","endTime":"0","summary":"Healthcare stocks were steady premarket Monday, with the iShares Biotechnology ETF  inactive and the State Street Health Care Select Sector SPDR ETF  down a slight 0.1%.Novo Nordisk  is facing shareholder calls to develop new medicines and pursue acquisitions so that it could lower its dependence on its popular weight-loss treatments, the Financial Times reported, citing the company's investors. Shares of Novo Nordisk were down 4.7% pre-bell.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4532","NVOH","BK4599","THNR","PPH","IE00BKVL7J92.USD","BK4007","LABU","LU1093756325.SGD","IE00BZ1G4Q59.USD","OZEM","LU0154236417.USD","BK4581","NVOC","IBB","BK4585","XBI","LU1093756168.USD","BK4588","XLV","NVOX","NVO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669316610","title":"InspireMD Announces Amendments to Certain Series J and Series K Warrants, Providing Potential Gross Proceeds of Up to $11 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2669316610","media":"GlobeNewswire","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669316610?lang=en_us&edition=fundamental","pubTime":"2026-09-21 21:00","pubTimestamp":1789995600,"startTime":"0","endTime":"0","summary":"- Amendments align trigger event of existing warrants with anticipated FDA approval of CGuard Prime 80 cm, which the Company continues to anticipate in Q4 2026 - - The amended warrants, if exercised i","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/09/21/3365503/0/en/inspiremd-announces-amendments-to-certain-series-j-and-series-k-warrants-providing-potential-gross-proceeds-of-up-to-11-million.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["GNMX","NSPR","PINK","BMED","IBB","BK4585","RSPH","GDOC","PSCH","BBP","BK4198","MRNX","IDNA","NVIB","LFSC","MRNY","SYNB","IEIH","BK4588","TBXU","MEDI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669684681","title":"Tiziana Life Sciences Completes Last Patient Visit in Phase 2a INFORM-MS Trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2669684681","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669684681?lang=en_us&edition=fundamental","pubTime":"2026-09-21 19:27","pubTimestamp":1789990051,"startTime":"0","endTime":"0","summary":"Tiziana Life Sciences ( ($TLSA) ) has shared an announcement. Tiziana Life Sciences Ltd, a clinical-stage biotechnology company specializing in imm...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/tiziana-life-sciences-completes-last-patient-visit-in-phase-2a-inform-ms-trial?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/tiziana-life-sciences-completes-last-patient-visit-in-phase-2a-inform-ms-trial?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BBC","FHLC","LNGR","BK4585","BBP","JDOC","BK4588","AGNG","DARP","FWD","SYNB","XT","IBB","RSPH","IEIH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669893168","title":"Immunome initiated with a Buy at Alliance Global","url":"https://stock-news.laohu8.com/highlight/detail?id=2669893168","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669893168?lang=en_us&edition=fundamental","pubTime":"2026-09-21 19:05","pubTimestamp":1789988705,"startTime":"0","endTime":"0","summary":"Alliance Global initiated coverage of Immunome (IMNM) with a Buy rating and $32 price target Immunome is a biotechnology company focused on develop...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/immunome-initiated-with-a-buy-at-alliance-global-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/immunome-initiated-with-a-buy-at-alliance-global-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4588","FWD","FHLC","BK4563","DARP","IBB","AGNG","BK4585","IEIH","JDOC","LNGR","RSPH","SYNB","BK4139","IMNM","XT","BBP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669315293","title":"Vertex Pharmaceuticals Incorporated : Leerink Partners Resumes Coverage with Outperform Rating; Target Price $594","url":"https://stock-news.laohu8.com/highlight/detail?id=2669315293","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669315293?lang=en_us&edition=fundamental","pubTime":"2026-09-21 18:03","pubTimestamp":1789985027,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260921:nFWN45A0U1:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4532","IDNA","IE00BFTCPJ56.SGD","LU1093756325.SGD","LU2462157665.USD","LU2456880835.USD","BK4567","LU2468319806.SGD","LU1035775433.USD","BIB","BBH","LU0256863811.USD","PBE","LU2362541273.HKD","BK4139","LU1585245621.USD","IE00B19Z9P08.USD","GNMX","LU2362541513.USD","IE00BJT1NW94.SGD","LU1069344957.HKD","LU2236285917.USD","IE0009355771.USD","LU0823416689.USD","LU1093756168.USD","TBXU","IBB","IE00B4R5TH58.HKD","IE00B19Z3581.USD","VRTX","IBBQ","IE00BZ9MQY76.HKD","LU1778281490.HKD","IE00B894F039.SGD","LU0320765992.SGD","BK4533","BK4588","LU2362540622.SGD","LU2417539215.USD","LU0289739699.SGD","LU1674673428.USD","LU2089984988.USD","LU0234570918.USD","LU2324357040.USD","IE00BJJMRZ35.SGD","SG9999013999.USD","SG9999001176.SGD","LU0058720904.USD","LU0061475181.USD","LU0109394709.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669442151","title":"Ultragenyx price target raised to $35 from $32 at Barclays","url":"https://stock-news.laohu8.com/highlight/detail?id=2669442151","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669442151?lang=en_us&edition=fundamental","pubTime":"2026-09-21 17:10","pubTimestamp":1789981807,"startTime":"0","endTime":"0","summary":"Barclays raised the firm’s price target on Ultragenyx (RARE) to $35 from $32 and keeps an Overweight rating on the shares following FDA approval of...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/ultragenyx-price-target-raised-to-35-from-32-at-barclays-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/ultragenyx-price-target-raised-to-35-from-32-at-barclays-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["XLVX","PINK","BK4139","PSCH","MRNX","MRNY","IBB","TECB","RSPH","BK4588","GDOC","SYNB","IEIH","BMED","GNMX","MEDI","BK4585","IDNA","BBP","IYH","TBXU","FRTY","RARE","LABU","NVIB","LFSC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669156720","title":"Sino Biopharmaceutical Stock Rises 8.2% in Hong Kong, Outperforms Competitors","url":"https://stock-news.laohu8.com/highlight/detail?id=2669156720","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669156720?lang=en_us&edition=fundamental","pubTime":"2026-09-21 16:30","pubTimestamp":1789979400,"startTime":"0","endTime":"0","summary":"This article was automatically generated by Dow Jones using technology from Automated Insights.Shares of Sino Biopharmaceutical Ltd. rallied 8.2% to 5.92 Hong Kong dollars on what proved to be an all-around great trading session for the Hong Kong stock market, with the Hang Seng Index rising 1.2% to 25042.71.Sino Biopharmaceutical Ltd. closed 32% below its 52-week high of HK$8.65, which the company achieved Sept. 22.The stock outperformed some of its competitors, as CSPC Pharmaceutical Group Ltd. rose 7.6% and Amgen Inc. remained unchanged.Trading volume totaled 150.2 million shares, compared to the 50-day average of 89.1 million shares.Data source: Dow Jones Market Data, FactSet","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0889565916.HKD","LU0109394709.USD","BK4581","LU1571399168.USD","IE00BZ08YS42.EUR","LU2468319806.SGD","LU2242652126.USD","IE0009355771.USD","IE00BZ08YR35.GBP","BIB","AMGN","IE00B4R5TH58.HKD","BK4585","BK4588","01177","BK1521","HK0000165453.HKD","IBB","IE00BJJMRZ35.SGD","LU1023059063.AUD","LU2112291526.USD","LU1057294990.SGD","IE0002141913.USD","IE00B2B36J28.USD","IE00BZ08YT58.USD","PBE","LU2242646821.SGD","BK4533","LU0289739699.SGD","IE00BJT1NW94.SGD","SG9999001440.SGD","LU0868494617.USD","LU1061106388.HKD","PJP","BK4534","BK4566","BK4599","IE00BFTCPJ56.SGD","BK1589","IBBQ","LU0058720904.USD","LU0320765992.SGD","LU0122379950.USD","LU1983299246.USD","LU2089984988.USD","BK4139","TBXU","BK1191","BK1515","BBH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1181721651","title":"Innovative Drug Sector Heats Up: Spotlight on Pure-Play R&D Developers","url":"https://stock-news.laohu8.com/highlight/detail?id=1181721651","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1181721651?lang=en_us&edition=fundamental","pubTime":"2026-09-21 14:01","pubTimestamp":1789970464,"startTime":"0","endTime":"0","summary":"A bullish MACD crossover signal has emerged, indicating strong upward momentum for select pharmaceutical stocks. This technical indicator, often seen as a precursor to sustained gains, has caught the...","market":"other","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LFSC","159992","WRND","GSKH","APXH","BIOY","BK4588","06978","BBP","GDOC","BK4585","XLVI","SBIO","IBBQ","PBE","BK1161","IBB","LNGR","BK1574","MEDX"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":11,"pageCount":10,"totalSize":202,"code":"91000000","status":"200"}]}}